Use of the Toxicity Index in Evaluating Adverse Events in Anal Cancer Trials: Analysis of RTOG 9811 and RTOG 0529 : American Journal of Clinical Oncology

Secondary Logo

Journal Logo

Full Text Access for Subscribers:

You can read the full text of this article if you:

Access through Ovid
Original Articles: Gastrointestinal

Use of the Toxicity Index in Evaluating Adverse Events in Anal Cancer Trials

Analysis of RTOG 9811 and RTOG 0529

Kharofa, Jordan R. MD*; Yothers, Greg PhD; Kachnic, Lisa A. MD; Ajani, Jaffer MD§; Meyer, Joshua E. MD; Augspurger, Mark E. MD; Okawara, Gordon S. MD#; Garg, Madhur K. MD**; Schefter, Tracey E. MD††; Swanson, Todd A. MD‡‡; Doncals, Desiree E. MD§§; Kim, Hyun MD∥∥; Zaki, Bassem I. MD¶¶; Narayan, Samir MD##; Lee, R. Jeffery MD***; Mamon, Harvey J. MD, PhD†††; Schwartz, Michael A. MD‡‡‡; Moughan, Jennifer MS; Crane, Christopher H. MD§§§

Author Information
American Journal of Clinical Oncology: December 2022 - Volume 45 - Issue 12 - p 534-536
doi: 10.1097/COC.0000000000000955
  • Buy
  • SDC

Abstract

Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.